Mr. Suresh Vishnubhatla is Senior Vice President, Chief Technology Officer of Pharmerica Corporationration, since March 2011. Prior to joining the Company, he served as Senior Vice President and Chief Technology Officer of Millennium Pharmacy Systems, Inc. from January 2007. Prior to joining Millennium Pharmacy Systems, Inc., Mr. Vishnubhatla held positions with BodyMedia, Inc. from 2000 to 2006, finally serving as Senior Vice President, Products.
The company has Return on Asset of 5.32 % which means that on every $100 spent on asset it made $5.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.35 % implying that it generated $5.35 on every 100 dollars invested.
The company has 315.5 M in debt with debt to equity (D/E) ratio of 0.71 which is OK given its current industry classification. PharMerica Corporation has Current Ratio of 3.96 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
PharMerica Corporationration operates as an institutional pharmacy services company in the United States. PharMerica Corporation [PMC] is traded on New York Stock Exchange in USA. It is located in Louisville, KY and employs 5,000 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
0.19%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
